We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Kromek Group plc (KMK) Ordinary Shares 1p

Sell:5.50p Buy:5.70p 0 Change: No change
Market closed Prices as at close on 2 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:5.50p
Buy:5.70p
Change: No change
Market closed Prices as at close on 2 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:5.50p
Buy:5.70p
Change: No change
Market closed Prices as at close on 2 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Kromek Group plc is a developer of radiation detection and bio-detection technology solutions for the advanced imaging and chemical, biological, radiological, and nuclear (CBRN) detection segments. Its advanced imaging segment comprises the medical, security, and industrial markets. The Company provides its original equipment manufacturer customers with detector components based on its core cadmium zinc telluride (CZT) platform to detect of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings. In CBRN detection, the Company provides nuclear radiation detection solutions to the global homeland defense and security market. Its compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of dirty bombs. The Company is also developing bio-security solutions in the CBRN detection segment.

Contact details

Address:
NETPark, Thomas Wright Way
SEDGEFIELD
TS21 3FD
United Kingdom
Telephone:
+44 (01740) 626060
Website:
https://www.kromek.com/

Important dates

Future events
AGM 13 December 2024 13/12/24
Past events
Annual report 18 November 2024 18/11/24
Final results 28 October 2024 28/10/24
Annual report 28 October 2024 28/10/24
Trading Announcement 29 May 2024 29/05/24
General meeting 04 March 2024 04/03/24
Interim results 30 January 2024 30/01/24

General stock information

EPIC:
KMK
ISIN:
GB00BD7V5D43
Market cap:
£35.93 million
Shares in issue:
641.55 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Arnab Basu
    Chief Executive Officer, Executive Director
  • Paul Farquhar
    Chief Financial Officer, Executive Director, Company Secretary
  • Albertus Beumer
    Chief Operating Officer, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.